Pre-therapeutic blood dosimetry in patients with differentiated thyroid carcinoma using 124-iodine: Predicted blood doses correlate with changes in blood cell counts after radioiodine therapy and depend on modes of TSH stimulation and number of preceding radioiodine therapies